首页 > 最新文献

Annals of Diagnostic Pathology最新文献

英文 中文
Evaluation of whole-slide imaging for diagnosing frozen sections 整片成像诊断冰冻切片的评价。
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-12-18 DOI: 10.1016/j.anndiagpath.2024.152431
Muhammad Ahsan , Fizza Jahangir , Saira Rathore , Mahrukh Mumtaz , Samina Zaman
A promising application of digital pathology is the use of Whole slide imaging (WSI) for rapid and remote intraoperative consultations. Based on recommendations from the College of American Pathologists, we compared diagnostic accuracy and technical analysis of WSI with optical microscopy (OM) for reporting frozen sections (FS). A series of 105 consecutive FS cases were included in our study and were categorized as primary diagnosis, assessment of margin status, and lymph node status. A surgical pathologist reviewed all WSI digital slides of FS cases online and their corresponding glass slides using OM after a 2-week washout period. Technical and diagnostic parameters for remote reporting of frozen sections using WSI were compared to routine OM. Diagnostic agreement between WSI and OM in the FS cases was 100 %. In comparison with the reference standard (original sign-out diagnosis), the overall diagnostic accuracy of WSI and OM was 99.04 %. Scan time per slide averaged 103.89 s. Mean diagnostic assessment time for OM was 17.48 s, while it was 26.62 s for WSI, with a mean difference of 9.14 s (P < .001). The overall mean turnaround time was 3.8 min for reporting a single slide using WSI based digital pathology system. The diagnostic accuracy of WSI is comparable to that of conventional OM. Therefore, we conclude that WSI based digital pathology systems can be safely implemented and integrated into a laboratory workflow as an alternative to conventional OM.
数字病理学的一个有前途的应用是使用全切片成像(WSI)快速和远程术中咨询。根据美国病理学家学会的建议,我们比较了WSI与光学显微镜(OM)报告冷冻切片(FS)的诊断准确性和技术分析。我们的研究纳入了105例连续的FS病例,并将其分为初步诊断、边缘状态评估和淋巴结状态。外科病理学家在2周的洗脱期后回顾了所有FS病例的WSI数字切片和相应的OM玻璃切片。使用WSI远程报告冷冻切片的技术和诊断参数与常规OM进行了比较。在FS病例中,WSI和OM的诊断一致性为100%。与参考标准(原签出诊断)相比,WSI和OM的总体诊断准确率为99.04%。每张幻灯片平均扫描时间为103.89秒。OM的平均诊断评估时间为17.48 s, WSI的平均诊断评估时间为26.62 s,平均差异为9.14 s (P < 0.05)
{"title":"Evaluation of whole-slide imaging for diagnosing frozen sections","authors":"Muhammad Ahsan ,&nbsp;Fizza Jahangir ,&nbsp;Saira Rathore ,&nbsp;Mahrukh Mumtaz ,&nbsp;Samina Zaman","doi":"10.1016/j.anndiagpath.2024.152431","DOIUrl":"10.1016/j.anndiagpath.2024.152431","url":null,"abstract":"<div><div>A promising application of digital pathology is the use of Whole slide imaging (WSI) for rapid and remote intraoperative consultations. Based on recommendations from the College of American Pathologists, we compared diagnostic accuracy and technical analysis of WSI with optical microscopy (OM) for reporting frozen sections (FS). A series of 105 consecutive FS cases were included in our study and were categorized as primary diagnosis, assessment of margin status, and lymph node status. A surgical pathologist reviewed all WSI digital slides of FS cases online and their corresponding glass slides using OM after a 2-week washout period. Technical and diagnostic parameters for remote reporting of frozen sections using WSI were compared to routine OM. Diagnostic agreement between WSI and OM in the FS cases was 100 %. In comparison with the reference standard (original sign-out diagnosis), the overall diagnostic accuracy of WSI and OM was 99.04 %. Scan time per slide averaged 103.89 s. Mean diagnostic assessment time for OM was 17.48 s, while it was 26.62 s for WSI, with a mean difference of 9.14 s (<em>P</em> &lt; .001). The overall mean turnaround time was 3.8 min for reporting a single slide using WSI based digital pathology system. The diagnostic accuracy of WSI is comparable to that of conventional OM. Therefore, we conclude that WSI based digital pathology systems can be safely implemented and integrated into a laboratory workflow as an alternative to conventional OM.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"75 ","pages":"Article 152431"},"PeriodicalIF":1.5,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass-forming isolated ischemic necrosis of the cecum mimicking malignancy: Clinicopathologic features of 11 cases 模拟恶性肿瘤的盲肠块状孤立性缺血性坏死:11例临床病理特征。
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-12-14 DOI: 10.1016/j.anndiagpath.2024.152428
Xiaoyan Liao , Douglas K. Rex , Dongwei Zhang
Isolated ischemic necrosis of the cecum (INC) is an uncommon benign condition that occurs most often in elderly patients. The clinical presentation and radiographic findings often mimic acute appendicitis or malignancy. This study aimed to investigate the clinicopathologic features of mass-forming INC. Eleven INC patients who presented with cecal masses were identified by searching the electronic medical record system in two large academic centers. The clinical and pathological features, including symptoms, imaging, endoscopic and surgical findings, histomorphology, and follow-up, were retrospectively analyzed. The study cohort included 4 males and 7 females, with a median age 72 (range 43–87) years. Common clinical presentations included right lower quadrant abdominal pain, nausea and vomiting, and bloody diarrhea. Nine patients had hypertension and cardiovascular diseases, including coronary artery disease, congestive heart failure, atrial fibrillation, and heart valve disease. All patients had a mass in the cecum by endoscopy and/or imaging studies, clinically suspicious for malignancy. The median mass size was 5 (range 3.1–6) cm. Six patients received non-surgical treatment after the biopsy specimen proved a benign histologic pattern of ischemic necrosis. The remaining 5 patients underwent right hemicolectomy. Pathologic examination of the biopsy or resection specimens showed similar histologic changes such as mucosal denudation, ulceration, necrosis, crypt withering and loss, and lamina propria hyalinization, findings consistent with ischemic necrosis. No malignancy was identified in any case. After a median follow-up of 78 (range 3–121) months, 10 patients were still alive. Only 1 patient died and this was from other causes and 96 months later. Mass-forming INC is a rare and unique variant of ischemic colitis that occurs in elderly patients with a low flow state. It is a benign condition with a favorable prognosis. INC should be considered in patients with long-standing hypertension or cardiovascular disease who present with right lower quadrant abdominal pain and cecal mass. Biopsy of the mass with pathologic examination helps make a diagnosis, assess the disease severity, and rule out malignancy. Awareness of this rare entity is important to avoid unnecessary resections in these patients.
盲肠孤立性缺血性坏死(INC)是一种不常见的良性疾病,多发于老年患者。其临床表现和影像学检查结果常与急性阑尾炎或恶性肿瘤相似。本研究旨在探讨肿块型 INC 的临床病理特征。通过检索两个大型学术中心的电子病历系统,确定了 11 名出现盲肠肿块的 INC 患者。研究人员回顾性分析了患者的临床和病理特征,包括症状、影像学、内镜和手术结果、组织形态学和随访情况。研究对象包括4名男性和7名女性,中位年龄为72岁(43-87岁)。常见的临床表现包括右下腹痛、恶心呕吐和血性腹泻。九名患者患有高血压和心血管疾病,包括冠状动脉疾病、充血性心力衰竭、心房颤动和心脏瓣膜疾病。通过内窥镜检查和/或造影检查,所有患者的盲肠都有肿块,临床上怀疑为恶性肿瘤。肿块大小的中位数为 5 厘米(3.1-6 厘米)。在活检标本证实为缺血性坏死的良性组织学模式后,6 名患者接受了非手术治疗。其余 5 名患者接受了右半结肠切除术。活检或切除标本的病理学检查显示了类似的组织学变化,如粘膜变性、溃疡、坏死、隐窝枯萎和消失以及固有膜透明化,这些结果与缺血性坏死一致。所有病例均未发现恶性肿瘤。中位随访 78 个月(3-121 个月)后,10 名患者仍然存活。只有一名患者在 96 个月后死于其他原因。肿块型 INC 是缺血性结肠炎的一种罕见而独特的变异型,多发于低流量状态的老年患者。它是一种良性疾病,预后良好。长期高血压或心血管疾病患者出现右下腹痛和盲肠肿块时应考虑 INC。对肿块进行活检和病理检查有助于确诊、评估疾病的严重程度并排除恶性肿瘤。对这种罕见病症的认识非常重要,可避免对这些患者进行不必要的切除手术。
{"title":"Mass-forming isolated ischemic necrosis of the cecum mimicking malignancy: Clinicopathologic features of 11 cases","authors":"Xiaoyan Liao ,&nbsp;Douglas K. Rex ,&nbsp;Dongwei Zhang","doi":"10.1016/j.anndiagpath.2024.152428","DOIUrl":"10.1016/j.anndiagpath.2024.152428","url":null,"abstract":"<div><div>Isolated ischemic necrosis of the cecum (INC) is an uncommon benign condition that occurs most often in elderly patients. The clinical presentation and radiographic findings often mimic acute appendicitis or malignancy. This study aimed to investigate the clinicopathologic features of mass-forming INC. Eleven INC patients who presented with cecal masses were identified by searching the electronic medical record system in two large academic centers. The clinical and pathological features, including symptoms, imaging, endoscopic and surgical findings, histomorphology, and follow-up, were retrospectively analyzed. The study cohort included 4 males and 7 females, with a median age 72 (range 43–87) years. Common clinical presentations included right lower quadrant abdominal pain, nausea and vomiting, and bloody diarrhea. Nine patients had hypertension and cardiovascular diseases, including coronary artery disease, congestive heart failure, atrial fibrillation, and heart valve disease. All patients had a mass in the cecum by endoscopy and/or imaging studies, clinically suspicious for malignancy. The median mass size was 5 (range 3.1–6) cm. Six patients received non-surgical treatment after the biopsy specimen proved a benign histologic pattern of ischemic necrosis. The remaining 5 patients underwent right hemicolectomy. Pathologic examination of the biopsy or resection specimens showed similar histologic changes such as mucosal denudation, ulceration, necrosis, crypt withering and loss, and lamina propria hyalinization, findings consistent with ischemic necrosis. No malignancy was identified in any case. After a median follow-up of 78 (range 3–121) months, 10 patients were still alive. Only 1 patient died and this was from other causes and 96 months later. Mass-forming INC is a rare and unique variant of ischemic colitis that occurs in elderly patients with a low flow state. It is a benign condition with a favorable prognosis. INC should be considered in patients with long-standing hypertension or cardiovascular disease who present with right lower quadrant abdominal pain and cecal mass. Biopsy of the mass with pathologic examination helps make a diagnosis, assess the disease severity, and rule out malignancy. Awareness of this rare entity is important to avoid unnecessary resections in these patients.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"75 ","pages":"Article 152428"},"PeriodicalIF":1.5,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of large cribriform carcinoma and “unfavorable histology” with other Gleason pattern 4 subtypes: A proof-of-principle study evaluating 485 radical prostatectomy specimens with proposal for the concept of “borderline histology” 大筛状癌和“不良组织学”与其他Gleason模式4亚型的相关性:一项原则性研究评估了485例根治性前列腺切除术标本,并提出了“边缘组织学”的概念。
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-12-05 DOI: 10.1016/j.anndiagpath.2024.152427
Jane K. Nguyen , Jianbo Li , Chien-Kuang C. Ding , Christopher J. Weight , Jesse K. McKenney
Prostatic adenocarcinomas with large cribriform glands/intraductal carcinoma (LC/IDC), or the recently proposed unfavorable histology, are associated with adverse outcomes after radical prostatectomy. However, Gleason pattern 4 carcinomas without LC/IDC (or unfavorable histology) have minimal risk for aggressive clinical behavior after prostatectomy. As proof-of-principle study, we collected a cohort of 485 radical prostatectomy specimens to assess correlations between different subtypes of Gleason pattern 4 disease and the presence of adjacent high-risk prostatic adenocarcinoma, defined as LC/IDC or unfavorable histology. All prostatectomies were completely embedded, and all slides re-reviewed to record Gleason score/Grade Group, diameter of the largest cribriform gland (i.e. the longest cross-sectional distance), and all architectural patterns of carcinoma utilizing previously described Canary methodology. The presence and percent of LC/IDC (defined as >0.25 mm) was determined. We also evaluated correlation with the recently proposed “unfavorable histology” as a secondary endpoint. Complex Gleason pattern 4 subtypes, distinct from LC/IDC and unfavorable histology, were termed “borderline histology” and defined as the presence of any of the following patterns: small cribriform/glomeruloid architecture (≤0.25 mm), dominant population of poorly formed glands/small nests, simple glomerulations, and epithelial complexity associated with extravasated mucin (beyond typical mucinous fibroplasia pattern and not containing cribriform >0.25 mm). Comparisons between recorded variables and LC/IDC (or unfavorable histology) utilized the Wilcoxon test for continuous variables and chi-squared test or Fisher's test for categorical variables. Pearson or phi correlation coefficients were used to assess the association between two variables. “Borderline histology” was significantly correlated to LC/IDC (r = 0.55) and unfavorable histology (r = 0.607), both p < 0.001. Specifically, small cribriform/small glomeruloid architecture had the strongest correlation, compared to the other “borderline histology” subtypes (r = 0.646). We demonstrate that “borderline histology” has a strong association with the concomitant presence of high-risk prostate cancer by current histologic definitions (i.e. LC/IDC and unfavorable histology). This proof-of-principle study suggests that large cohort biopsy-RP correlation studies are needed, as the presence of these patterns on biopsy could potentially aid preoperative risk stratification for patients without other high-risk features at initial evaluation.
前列腺腺癌合并大筛状腺/导管内癌(LC/IDC),或最近提出的不良组织学,与根治性前列腺切除术后的不良预后相关。然而,没有LC/IDC(或不良组织学)的Gleason 4型癌在前列腺切除术后出现侵袭性临床行为的风险最小。作为原则性研究,我们收集了485例根治性前列腺切除术标本,以评估不同亚型Gleason 4型疾病与邻近高危前列腺腺癌(定义为LC/IDC或不良组织学)存在之间的相关性。所有的前列腺切除术都完全包埋,所有的切片都重新检查以记录Gleason评分/分级组,最大筛状腺的直径(即最长的横截距离),以及使用先前描述的Canary方法的所有癌的结构模式。测定LC/IDC(定义为>0.25 mm)的存在和百分比。我们还评估了与最近提出的“不良组织学”作为次要终点的相关性。复杂Gleason模式4亚型,不同于LC/IDC和不利的组织学,被称为“交界性组织学”,定义为存在以下任何一种模式:小筛状/肾小球结构(≤0.25 mm),优势群体形成不良的腺体/小巢,简单的肾小球,以及与黏液外渗相关的上皮复杂性(超出典型的黏液纤维增生模式,不含筛状>0.25 mm)。记录变量与LC/IDC(或不利组织学)之间的比较使用连续变量的Wilcoxon检验和分类变量的卡方检验或Fisher检验。使用Pearson或phi相关系数来评估两个变量之间的关联。“边缘组织学”与LC/IDC (r = 0.55)和不良组织学(r = 0.607)显著相关,均为p
{"title":"Correlation of large cribriform carcinoma and “unfavorable histology” with other Gleason pattern 4 subtypes: A proof-of-principle study evaluating 485 radical prostatectomy specimens with proposal for the concept of “borderline histology”","authors":"Jane K. Nguyen ,&nbsp;Jianbo Li ,&nbsp;Chien-Kuang C. Ding ,&nbsp;Christopher J. Weight ,&nbsp;Jesse K. McKenney","doi":"10.1016/j.anndiagpath.2024.152427","DOIUrl":"10.1016/j.anndiagpath.2024.152427","url":null,"abstract":"<div><div>Prostatic adenocarcinomas with large cribriform glands/intraductal carcinoma (LC/IDC), or the recently proposed unfavorable histology, are associated with adverse outcomes after radical prostatectomy. However, Gleason pattern 4 carcinomas without LC/IDC (or unfavorable histology) have minimal risk for aggressive clinical behavior after prostatectomy. As proof-of-principle study, we collected a cohort of 485 radical prostatectomy specimens to assess correlations between different subtypes of Gleason pattern 4 disease and the presence of adjacent high-risk prostatic adenocarcinoma, defined as LC/IDC or unfavorable histology. All prostatectomies were completely embedded, and all slides re-reviewed to record Gleason score/Grade Group, diameter of the largest cribriform gland (i.e. the longest cross-sectional distance), and all architectural patterns of carcinoma utilizing previously described Canary methodology. The presence and percent of LC/IDC (defined as &gt;0.25 mm) was determined. We also evaluated correlation with the recently proposed “unfavorable histology” as a secondary endpoint. Complex Gleason pattern 4 subtypes, distinct from LC/IDC and unfavorable histology, were termed “borderline histology” and defined as the presence of any of the following patterns: small cribriform/glomeruloid architecture (≤0.25 mm), dominant population of poorly formed glands/small nests, simple glomerulations, and epithelial complexity associated with extravasated mucin (beyond typical mucinous fibroplasia pattern and not containing cribriform &gt;0.25 mm). Comparisons between recorded variables and LC/IDC (or unfavorable histology) utilized the Wilcoxon test for continuous variables and chi-squared test or Fisher's test for categorical variables. Pearson or phi correlation coefficients were used to assess the association between two variables. “Borderline histology” was significantly correlated to LC/IDC (r = 0.55) and unfavorable histology (r = 0.607), both p &lt; 0.001. Specifically, small cribriform/small glomeruloid architecture had the strongest correlation, compared to the other “borderline histology” subtypes (r = 0.646). We demonstrate that “borderline histology” has a strong association with the concomitant presence of high-risk prostate cancer by current histologic definitions (i.e. LC/IDC and unfavorable histology). This proof-of-principle study suggests that large cohort biopsy-RP correlation studies are needed, as the presence of these patterns on biopsy could potentially aid preoperative risk stratification for patients without other high-risk features at initial evaluation.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"75 ","pages":"Article 152427"},"PeriodicalIF":1.5,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the swirl sign: A radiologic-pathologic correlation in deep angiomyxoma 揭示漩涡征象:深血管粘液瘤的影像学-病理相关性。
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-29 DOI: 10.1016/j.anndiagpath.2024.152426
Hiroshi Yoshida , Nao Kikkawa , Waku Takigawa , Masaya Uno , Mitsuya Ishikawa
Deep angiomyxoma (DA) is a rare, slow-growing soft tissue tumor typically affecting women of reproductive age. Despite its benign histology, it poses significant clinical challenges due to local invasiveness and high recurrence. Accurate diagnosis through radiologic imaging, particularly MRI, is essential for guiding treatment. One key imaging feature of DA is the “swirl sign,” a distinctive pattern on T2-weighted images. However, its histological basis remains unclear. Here, we present a case of DA in a 46-year-old woman, highlighting the correlation between radiologic and histopathologic findings. MRI showed the characteristic swirl sign, which histologically corresponded to straight-running blood vessels aligned with the tumor's long axis, supported by collagen fibers within an edematous stroma. This case offers novel insight into the origins of the swirl sign and provides research questions on this sign. Further research is needed to explore its potential as a biomarker for tumor growth and aggressiveness.
深血管粘液瘤(DA)是一种罕见的,生长缓慢的软组织肿瘤,通常影响育龄妇女。尽管其组织学为良性,但由于其局部侵袭性和高复发率,给临床带来了重大挑战。通过放射成像,特别是核磁共振成像进行准确诊断对于指导治疗至关重要。DA的一个关键成像特征是“漩涡征”,这是t2加权图像上的一种独特的模式。然而,其组织学基础尚不清楚。在此,我们报告一位46岁女性DA病例,强调放射学和组织病理学结果之间的相关性。MRI显示特征性旋流征象,在组织学上对应于与肿瘤长轴对齐的直行血管,由水肿间质内的胶原纤维支撑。这个案例对漩涡标志的起源提供了新的见解,并提供了关于这个标志的研究问题。需要进一步的研究来探索其作为肿瘤生长和侵袭性的生物标志物的潜力。
{"title":"Unveiling the swirl sign: A radiologic-pathologic correlation in deep angiomyxoma","authors":"Hiroshi Yoshida ,&nbsp;Nao Kikkawa ,&nbsp;Waku Takigawa ,&nbsp;Masaya Uno ,&nbsp;Mitsuya Ishikawa","doi":"10.1016/j.anndiagpath.2024.152426","DOIUrl":"10.1016/j.anndiagpath.2024.152426","url":null,"abstract":"<div><div>Deep angiomyxoma (DA) is a rare, slow-growing soft tissue tumor typically affecting women of reproductive age. Despite its benign histology, it poses significant clinical challenges due to local invasiveness and high recurrence. Accurate diagnosis through radiologic imaging, particularly MRI, is essential for guiding treatment. One key imaging feature of DA is the “swirl sign,” a distinctive pattern on T2-weighted images. However, its histological basis remains unclear. Here, we present a case of DA in a 46-year-old woman, highlighting the correlation between radiologic and histopathologic findings. MRI showed the characteristic swirl sign, which histologically corresponded to straight-running blood vessels aligned with the tumor's long axis, supported by collagen fibers within an edematous stroma. This case offers novel insight into the origins of the swirl sign and provides research questions on this sign. Further research is needed to explore its potential as a biomarker for tumor growth and aggressiveness.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"75 ","pages":"Article 152426"},"PeriodicalIF":1.5,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fungal Rhinosinusitis: An integrated diagnostic approach 真菌性鼻窦炎:一种综合诊断方法
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-26 DOI: 10.1016/j.anndiagpath.2024.152415
R Soundarya , H.C Deepa , Peralam Yegneswaran Prakash , V Geetha
Classification of fungal rhinosinusitis (FRS) based on histomorphology and clinical presentation aids in early diagnosis and prompt patient management. In this retrospective observational study, clinicopathologic findings in patients diagnosed with fungal rhinosinusitis between January 2019 and December 2021 were evaluated. Clinical and imaging findings were retrieved from hospital records; slides from routine and histochemical studies were reviewed, and the cases were classified into non-invasive [fungal ball (FB) and allergic fungal rhinosinusitis (AFRS)] and invasive FRS [acute invasive fungal rhinosinusitis (AIFRS), chronic invasive fungal rhinosinusitis (CIFRS) and chronic invasive granulomatous fungal rhinosinusitis (CGFRS)]. Fungal cultures were also compared with histopathology. Of the 85 patients in the study, 34% were non-invasive (86% FB,10% AFRS, and 4% unclassified), and 66% were invasive (70% AIFRS, 21% CGFRS, and 9% CIFRS). The mean age of patients was 51 years, with a male-to-female ratio of 1.5:1. The most common comorbidity was diabetes with COVID-19 co-infection. Culture reports were available for 77 patients, of which 36 cases had growth, the majority of which were Aspergillus; 7 patients had coinfection with Aspergillus and Mucorales. Comparing histopathology to the gold standard mycology for Aspergillus, a sensitivity of 90%, specificity of 96%, and Cohen's Kappa of 0.8 was achieved. This study emphasizes the value of an integrated diagnostic approach in arriving at an appropriate diagnosis. In resource-limited settings, histopathological evaluation can be a valuable screening tool, aiding in early diagnosis.
真菌性鼻窦炎(FRS)的分类基于组织形态学和临床表现有助于早期诊断和及时的患者管理。在这项回顾性观察性研究中,对2019年1月至2021年12月诊断为真菌性鼻窦炎的患者的临床病理结果进行了评估。临床和影像学结果从医院记录中检索;回顾常规和组织化学切片,将病例分为非侵袭性[真菌球(FB)和过敏性真菌性鼻窦炎(AFRS)]和侵袭性[急性侵袭性真菌性鼻窦炎(AIFRS),慢性侵袭性真菌性鼻窦炎(CIFRS)和慢性侵袭性肉芽肿性真菌性鼻窦炎(CGFRS)]。真菌培养也与组织病理学进行比较。在研究中的85例患者中,34%为非侵入性(86% FB,10% AFRS, 4%未分类),66%为侵入性(70% AIFRS, 21% CGFRS, 9% CIFRS)。患者平均年龄51岁,男女比例为1.5:1。最常见的合并症是糖尿病合并COVID-19感染。77例患者有培养报告,其中36例有生长,以曲霉菌为主;7例合并曲霉和毛霉感染。将组织病理学与真菌学的金标准曲霉进行比较,灵敏度为90%,特异性为96%,科恩Kappa为0.8。本研究强调了综合诊断方法在达到适当诊断中的价值。在资源有限的情况下,组织病理学评估是一种有价值的筛查工具,有助于早期诊断。
{"title":"Fungal Rhinosinusitis: An integrated diagnostic approach","authors":"R Soundarya ,&nbsp;H.C Deepa ,&nbsp;Peralam Yegneswaran Prakash ,&nbsp;V Geetha","doi":"10.1016/j.anndiagpath.2024.152415","DOIUrl":"10.1016/j.anndiagpath.2024.152415","url":null,"abstract":"<div><div>Classification of fungal rhinosinusitis (FRS) based on histomorphology and clinical presentation aids in early diagnosis and prompt patient management. In this retrospective observational study, clinicopathologic findings in patients diagnosed with fungal rhinosinusitis between January 2019 and December 2021 were evaluated. Clinical and imaging findings were retrieved from hospital records; slides from routine and histochemical studies were reviewed, and the cases were classified into non-invasive [fungal ball (FB) and allergic fungal rhinosinusitis (AFRS)] and invasive FRS [acute invasive fungal rhinosinusitis (AIFRS), chronic invasive fungal rhinosinusitis (CIFRS) and chronic invasive granulomatous fungal rhinosinusitis (CGFRS)]. Fungal cultures were also compared with histopathology. Of the 85 patients in the study, 34% were non-invasive (86% FB,10% AFRS, and 4% unclassified), and 66% were invasive (70% AIFRS, 21% CGFRS, and 9% CIFRS). The mean age of patients was 51 years, with a male-to-female ratio of 1.5:1. The most common comorbidity was diabetes with COVID-19 co-infection. Culture reports were available for 77 patients, of which 36 cases had growth, the majority of which were Aspergillus; 7 patients had coinfection with Aspergillus and Mucorales. Comparing histopathology to the gold standard mycology for Aspergillus, a sensitivity of 90%, specificity of 96%, and Cohen's Kappa of 0.8 was achieved. This study emphasizes the value of an integrated diagnostic approach in arriving at an appropriate diagnosis. In resource-limited settings, histopathological evaluation can be a valuable screening tool, aiding in early diagnosis.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"75 ","pages":"Article 152415"},"PeriodicalIF":1.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142743037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Castleman disease-type histopathological patterns of lymph nodes in patients with plasma cell neoplasia and POEMS syndrome 浆细胞瘤和POEMS综合征患者淋巴结的Castleman病型组织病理学模式
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-26 DOI: 10.1016/j.anndiagpath.2024.152414
Laura Rodriguez-Merino, Santiago Montes-Moreno
Plasma cell neoplasia and POEMS syndrome patients may present Castleman disease (CD)-type features in lymph nodes. Our aim was to better characterize the histopathological patterns found in plasma cell neoplasia associated CD and to improve the detection of clonal plasma cell populations in the lymph node biopsies of these patients.
Lymph node and bone marrow samples from six cases with plasma cell neoplasia associated CD, including POEMS syndrome and multiple myeloma were analyzed. A complete analysis including morphology, IHC and PCR-based clonality detection in the lymph node biopsies and morphology; IHC and FCM in the bone marrow biopsies was done. Correlation with clinical and laboratory features was performed.
Both plasma cell rich and hyper vascular Castleman disease like histopathological features were found. In two out of six cases, sheets of plasma cells with light chain and isotype restriction were identified in the lymph nodes. B cell clonality analysis provided evidence of clonal populations in 5 out of 6 cases, increasing the sensitivity for the detection in cases without morphologically identifiable monotypic plasma cells. None of the twelve control cases with iMCD and HHV-8 positive CD showed clonal populations.
In conclusion, the combination of morphology, complete immunophenotyping and B cell clonality analysis in the lymph node biopsy may provide evidence of clonal populations in up to 83 % of cases with plasma cell neoplasia/POEMS syndrome associated Castleman disease. Clinical work-up for the confirmation of plasma cell dyscrasia is advisable in such cases.
浆细胞瘤和POEMS综合征患者可能在淋巴结中出现Castleman病(CD)型特征。我们的目的是更好地表征与CD相关的浆细胞瘤的组织病理学模式,并提高在这些患者的淋巴结活检中克隆浆细胞群的检测。我们分析了6例浆细胞瘤伴CD的淋巴结和骨髓样本,包括POEMS综合征和多发性骨髓瘤。完整的分析,包括形态学,免疫组化和基于pcr的淋巴结活检和形态学克隆检测;骨髓活检行免疫组化和流式细胞仪检查。与临床和实验室特征进行相关性分析。浆细胞丰富和高血管性Castleman病样组织病理特征均可见。在6例中的2例中,在淋巴结中发现了具有轻链和同型限制的浆细胞片。B细胞克隆分析为6例病例中的5例提供了克隆群体的证据,提高了对无形态可识别的单型浆细胞病例检测的敏感性。12例iMCD和HHV-8阳性CD的对照病例均未出现克隆群体。总之,淋巴结活检中形态学、完全免疫表型和B细胞克隆分析的结合可能为高达83%的浆细胞瘤变/POEMS综合征相关Castleman病病例提供克隆群体的证据。在这种情况下,建议进行临床检查以确认浆细胞病变。
{"title":"Castleman disease-type histopathological patterns of lymph nodes in patients with plasma cell neoplasia and POEMS syndrome","authors":"Laura Rodriguez-Merino,&nbsp;Santiago Montes-Moreno","doi":"10.1016/j.anndiagpath.2024.152414","DOIUrl":"10.1016/j.anndiagpath.2024.152414","url":null,"abstract":"<div><div>Plasma cell neoplasia and POEMS syndrome patients may present Castleman disease (CD)-type features in lymph nodes. Our aim was to better characterize the histopathological patterns found in plasma cell neoplasia associated CD and to improve the detection of clonal plasma cell populations in the lymph node biopsies of these patients.</div><div>Lymph node and bone marrow samples from six cases with plasma cell neoplasia associated CD, including POEMS syndrome and multiple myeloma were analyzed. A complete analysis including morphology, IHC and PCR-based clonality detection in the lymph node biopsies and morphology; IHC and FCM in the bone marrow biopsies was done. Correlation with clinical and laboratory features was performed.</div><div>Both plasma cell rich and hyper vascular Castleman disease like histopathological features were found. In two out of six cases, sheets of plasma cells with light chain and isotype restriction were identified in the lymph nodes. B cell clonality analysis provided evidence of clonal populations in 5 out of 6 cases, increasing the sensitivity for the detection in cases without morphologically identifiable monotypic plasma cells. None of the twelve control cases with iMCD and HHV-8 positive CD showed clonal populations.</div><div>In conclusion, the combination of morphology, complete immunophenotyping and B cell clonality analysis in the lymph node biopsy may provide evidence of clonal populations in up to 83 % of cases with plasma cell neoplasia/POEMS syndrome associated Castleman disease. Clinical work-up for the confirmation of plasma cell dyscrasia is advisable in such cases.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"74 ","pages":"Article 152414"},"PeriodicalIF":1.5,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142748339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathology of rheumatoid meningitis: A report of 5 cases highlighting the importance of clinical correlation 类风湿性脑膜炎的病理学:5 例病例报告凸显临床相关性的重要性
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-22 DOI: 10.1016/j.anndiagpath.2024.152412
Samuel Guzman , B.K. Kleinschmidt-DeMasters
Rheumatoid meningitis (RM) presents with sufficiently wide-ranging, but non-specific, symptoms and neuroimaging features of pachy- and/or leptomeningeal thickening that it may be indistinguishable from subacute infectious meningitis. RA diagnosis variably antedates RM and serological confirmation by rheumatoid factor and anti-citrullinated peptide antibodies may not be present preoperatively. Thus, meningeal biopsy may be undertaken. Classic examples of RM show lymphoplasmacytic leptomeningeal inflammation and small vessel vasculitis, with rheumatoid nodules being less frequent. We reviewed our experience with 5 RM biopsies, as well as the literature, placing “classic” histological findings in perspective with biopsies showing less pathognomonic features. 5 RM cases were identified, 2 male: 3 female, ages 62–79 years. All patients had leptomeningeal enhancement by MRI and 2 had known negative RF serology prior to meningeal biopsy. In 1 case RF was initially negative, but on serological reassessment turned positive; 2 patients were diagnosed by clinical correlation. 4 leptomeningeal/superficial cortical biopsies manifested chronic lymphoplasmacytic inflammation with multinucleated giant cells, with discrete foci of deep blue/black necrosis with cellular debris (“dirty necrosis”) surrounded by a variably- developed palisade of histiocytes (rheumatoid nodules). The 5th showed only non-specific mononuclear cell inflammation. All showed variable degrees of diffuse astrocytosis and microgliosis of the cortex without microglial clusters or compact granulomas. Stains for microorganisms were negative. Diagnosis of RM can be suspected by the pathologist if the “classic” features of rheumatoid nodules are present on biopsy, but in some cases, only non-specific inflammation is present. Diagnosis necessitates correlation between clinical, serological, and histological features.
类风湿性脑膜炎(RM)具有广泛但非特异性的症状和神经影像学特征,即蝶骨和/或脑膜增厚,因此可能无法与亚急性感染性脑膜炎区分开来。类风湿因子和抗瓜氨酸肽抗体的血清学确认可能在术前并不存在。因此,可能需要进行脑膜活检。典型的 RM 表现为淋巴浆细胞性脑膜脑炎和小血管炎,类风湿结节较少见。我们回顾了 5 例 RM 活检的经验以及相关文献,将 "经典 "组织学结果与显示较少病理特征的活检结果进行对比。5例RM患者中,2男3女,年龄在62-79岁之间。所有患者的核磁共振成像均显示其脑膜增厚,其中2例在脑膜活检前RF血清学检测为阴性。1例患者的射频最初为阴性,但血清学重新评估后转为阳性;2例患者通过临床相关性确诊。4 例脑膜/皮质浅层活检病例表现为慢性淋巴细胞性炎症,伴有多核巨细胞,有不连续的深蓝/黑色坏死灶,有细胞碎片("脏坏死"),周围有发育不一的组织细胞栅(类风湿结节)。第 5 个只显示出非特异性单核细胞炎症。所有病例的皮质均出现不同程度的弥漫性星形细胞增多和小胶质细胞增多,但没有小胶质细胞簇或紧密肉芽肿。微生物染色呈阴性。如果活组织检查显示类风湿结节的 "典型 "特征,病理学家可怀疑诊断为 RM,但在某些病例中,仅显示非特异性炎症。诊断需要临床、血清学和组织学特征之间的相关性。
{"title":"Pathology of rheumatoid meningitis: A report of 5 cases highlighting the importance of clinical correlation","authors":"Samuel Guzman ,&nbsp;B.K. Kleinschmidt-DeMasters","doi":"10.1016/j.anndiagpath.2024.152412","DOIUrl":"10.1016/j.anndiagpath.2024.152412","url":null,"abstract":"<div><div>Rheumatoid meningitis (RM) presents with sufficiently wide-ranging, but non-specific, symptoms and neuroimaging features of pachy- and/or leptomeningeal thickening that it may be indistinguishable from subacute infectious meningitis. RA diagnosis variably antedates RM and serological confirmation by rheumatoid factor and anti-citrullinated peptide antibodies may not be present preoperatively. Thus, meningeal biopsy may be undertaken. Classic examples of RM show lymphoplasmacytic leptomeningeal inflammation and small vessel vasculitis, with rheumatoid nodules being less frequent. We reviewed our experience with 5 RM biopsies, as well as the literature, placing “classic” histological findings in perspective with biopsies showing less pathognomonic features. 5 RM cases were identified, 2 male: 3 female, ages 62–79 years. All patients had leptomeningeal enhancement by MRI and 2 had known negative RF serology prior to meningeal biopsy. In 1 case RF was initially negative, but on serological reassessment turned positive; 2 patients were diagnosed by clinical correlation. 4 leptomeningeal/superficial cortical biopsies manifested chronic lymphoplasmacytic inflammation with multinucleated giant cells, with discrete foci of deep blue/black necrosis with cellular debris (“dirty necrosis”) surrounded by a variably- developed palisade of histiocytes (rheumatoid nodules). The 5th showed only non-specific mononuclear cell inflammation. All showed variable degrees of diffuse astrocytosis and microgliosis of the cortex without microglial clusters or compact granulomas. Stains for microorganisms were negative. Diagnosis of RM can be suspected by the pathologist if the “classic” features of rheumatoid nodules are present on biopsy, but in some cases, only non-specific inflammation is present. Diagnosis necessitates correlation between clinical, serological, and histological features.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"74 ","pages":"Article 152412"},"PeriodicalIF":1.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does H3K27me3 expression play a role in patients with Blastic plasmacytoid dendritic cell neoplasm? A clinicopathologic analysis of 14 patients H3K27me3的表达在浆细胞性树突状细胞肿瘤患者中起作用吗?对14例患者的临床病理学分析
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-22 DOI: 10.1016/j.anndiagpath.2024.152413
Kuai Yu , Gang Meng , Hong He , Wenwen Li , Lixin Wang , Yuanxin Li , Xingyu Wang , Ying Huang , Juan He , Min Zhao , Tao Xie , Zeng Zhen , Dan Li
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive lymphohematopoietic malignancy associated with poor prognosis. We aimed to improve the understanding of BPDCN, explore its prognostic significance, and identify potential therapeutic targets. Data from 14 BPDCN patients were retrospectively collected and analyzed, focusing on their clinicopathological characteristics, diagnostic features, immunophenotype, treatment regimens, and prognostic factors. Additionally, immunohistochemistry was used to detect the expression of multiple oncogenes in BPDCN. The cohort comprised 14 patients (10 males, 4 females) with a median age of 63.5 years at the time of diagnosis. Of these specimens, H3K27me3, ASXL1, BAP1, RAC1, TCF4 and AURKA were highly expressed in BPDCN, with expression rates of 71.4 % (10/14), 92.9 % (13/14), 85.7 % (12/14), 100 % (13/13), 12/14 (85.7 %) and 46.2 % (6/13), respectively. The survival of patients in this cohort ranged from 1 to 84 months, with a median overall survival (OS) of 18.5 months. The survival rates for 1, 2, 3, 4 and 5 years were 71.43 %, 53.57 %, 44.64 %, 44.64 %, and 44.64 %, respectively. In the overall BPDCN cohort, patients with positive expression of H3K27me3 exhibited significantly better overall survival compared to those with negative expression H3K27me3 (P = 0.0056). Our analysis showed that the absence of H3K27me3 expression may indicate a poor prognosis in patients with BPDCN, and H3K27me3 may be a potential prognostic indicator for BPDCN.
增生性浆细胞树突状细胞肿瘤(BPDCN)是一种罕见的侵袭性淋巴造血恶性肿瘤,预后不良。我们的目的是加深对 BPDCN 的了解,探讨其预后意义,并确定潜在的治疗靶点。我们回顾性地收集并分析了14例BPDCN患者的数据,重点研究了他们的临床病理特征、诊断特点、免疫表型、治疗方案和预后因素。此外,研究人员还利用免疫组化技术检测了多种癌基因在 BPDCN 中的表达。研究组包括 14 名患者(10 名男性,4 名女性),诊断时的中位年龄为 63.5 岁。在这些标本中,H3K27me3、ASXL1、BAP1、RAC1、TCF4 和 AURKA 在 BPDCN 中高度表达,表达率分别为 71.4 %(10/14)、92.9 %(13/14)、85.7 %(12/14)、100 %(13/13)、12/14 (85.7 %) 和 46.2 %(6/13)。该组患者的生存期从 1 个月到 84 个月不等,中位总生存期(OS)为 18.5 个月。1年、2年、3年、4年和5年的生存率分别为71.43%、53.57%、44.64%、44.64%和44.64%。在整个BPDCN队列中,与H3K27me3表达阴性的患者相比,H3K27me3表达阳性的患者总生存率明显更高(P = 0.0056)。我们的分析表明,H3K27me3表达缺失可能预示着BPDCN患者的预后较差,H3K27me3可能是BPDCN的一个潜在预后指标。
{"title":"Does H3K27me3 expression play a role in patients with Blastic plasmacytoid dendritic cell neoplasm? A clinicopathologic analysis of 14 patients","authors":"Kuai Yu ,&nbsp;Gang Meng ,&nbsp;Hong He ,&nbsp;Wenwen Li ,&nbsp;Lixin Wang ,&nbsp;Yuanxin Li ,&nbsp;Xingyu Wang ,&nbsp;Ying Huang ,&nbsp;Juan He ,&nbsp;Min Zhao ,&nbsp;Tao Xie ,&nbsp;Zeng Zhen ,&nbsp;Dan Li","doi":"10.1016/j.anndiagpath.2024.152413","DOIUrl":"10.1016/j.anndiagpath.2024.152413","url":null,"abstract":"<div><div>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive lymphohematopoietic malignancy associated with poor prognosis. We aimed to improve the understanding of BPDCN, explore its prognostic significance, and identify potential therapeutic targets. Data from 14 BPDCN patients were retrospectively collected and analyzed, focusing on their clinicopathological characteristics, diagnostic features, immunophenotype, treatment regimens, and prognostic factors. Additionally, immunohistochemistry was used to detect the expression of multiple oncogenes in BPDCN. The cohort comprised 14 patients (10 males, 4 females) with a median age of 63.5 years at the time of diagnosis. Of these specimens, H3K27me3, ASXL1, BAP1, RAC1, TCF4 and AURKA were highly expressed in BPDCN, with expression rates of 71.4 % (10/14), 92.9 % (13/14), 85.7 % (12/14), 100 % (13/13), 12/14 (85.7 %) and 46.2 % (6/13), respectively. The survival of patients in this cohort ranged from 1 to 84 months, with a median overall survival (OS) of 18.5 months. The survival rates for 1, 2, 3, 4 and 5 years were 71.43 %, 53.57 %, 44.64 %, 44.64 %, and 44.64 %, respectively. In the overall BPDCN cohort, patients with positive expression of H3K27me3 exhibited significantly better overall survival compared to those with negative expression H3K27me3 (<em>P</em> = 0.0056). Our analysis showed that the absence of H3K27me3 expression may indicate a poor prognosis in patients with BPDCN, and H3K27me3 may be a potential prognostic indicator for BPDCN.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"74 ","pages":"Article 152413"},"PeriodicalIF":1.5,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank 对最近建立的荷兰全国性卵巢癌研究群岛生物库进行评估
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-19 DOI: 10.1016/j.anndiagpath.2024.152411
Hein S. Zelisse , Mignon D.J.M. van Gent , Constantijne H. Mom , Sander de Ridder , Malou L.H. Snijders , Marlou Heeling , Matthijs Stoter , Annegien Broeks , Hugo M. Horlings , Christianne A.R. Lok , Steven L. Bosch , Jurgen M. Piek , Joost Bart , Anna K.L. Reyners , G. Bea A. Wisman , Refika Yigit , Ingrid A. Boere , Margriet Collée , Floris H. Groenendijk , Maurice P.H.M. Jansen , Frederike Dijk
Fundamental and translational research in ovarian cancer aims to enhance understanding of disease mechanisms and improve treatment and survival outcomes. To support this, we established the Dutch multicenter, interdisciplinary Archipelago of Ovarian Cancer Research (AOCR) infrastructure, which includes a nationwide biobank. In this study, we share our experiences in establishing the infrastructure, offer guidance for similar initiatives, and evaluate the AOCR patient cohort. Key challenges included obtaining Data Protection Impact Assessment (DPIA) clearance, drafting the consortium agreement, and securing ethical approval from all hospitals. Over three years, 1093 patients were enrolled across 17 hospitals, resulting in the collection of 1339 tissue samples and 2280 blood samples. Of the 523 patients with currently available clinical and pathological data, 74 % (n = 387) had primary ovarian cancer. Among these patients, 73.4 % was diagnosed with high-grade serous ovarian carcinoma, and 80.9 % presented with advanced-stage disease. Surgery was performed on 93 % of patients with primary ovarian cancer, and chemotherapy was administered to 90.4 % of these patients. In conclusion, the AOCR biobank has established a robust foundation for future fundamental and translational ovarian cancer research. This manuscript provides valuable insights and guidance for developing future research infrastructures and biobanks, and contains detailed information about the AOCR patient cohort to date.
卵巢癌的基础研究和转化研究旨在加深对疾病机制的了解,改善治疗和生存效果。为此,我们建立了荷兰多中心、跨学科卵巢癌研究群岛(AOCR)基础设施,其中包括一个全国性的生物库。在本研究中,我们将分享建立该基础设施的经验,为类似的倡议提供指导,并对 AOCR 患者群进行评估。主要挑战包括获得数据保护影响评估 (DPIA) 许可、起草联盟协议以及获得所有医院的伦理批准。三年来,17 家医院共招募了 1093 名患者,采集了 1339 份组织样本和 2280 份血液样本。在目前有临床和病理数据的 523 名患者中,74%(n = 387)患有原发性卵巢癌。在这些患者中,73.4%被诊断为高级别浆液性卵巢癌,80.9%为晚期。93%的原发性卵巢癌患者接受了手术治疗,90.4%的患者接受了化疗。总之,AOCR 生物库为未来的卵巢癌基础研究和转化研究奠定了坚实的基础。本手稿为开发未来的研究基础设施和生物库提供了宝贵的见解和指导,并包含了迄今为止 AOCR 患者群的详细信息。
{"title":"Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank","authors":"Hein S. Zelisse ,&nbsp;Mignon D.J.M. van Gent ,&nbsp;Constantijne H. Mom ,&nbsp;Sander de Ridder ,&nbsp;Malou L.H. Snijders ,&nbsp;Marlou Heeling ,&nbsp;Matthijs Stoter ,&nbsp;Annegien Broeks ,&nbsp;Hugo M. Horlings ,&nbsp;Christianne A.R. Lok ,&nbsp;Steven L. Bosch ,&nbsp;Jurgen M. Piek ,&nbsp;Joost Bart ,&nbsp;Anna K.L. Reyners ,&nbsp;G. Bea A. Wisman ,&nbsp;Refika Yigit ,&nbsp;Ingrid A. Boere ,&nbsp;Margriet Collée ,&nbsp;Floris H. Groenendijk ,&nbsp;Maurice P.H.M. Jansen ,&nbsp;Frederike Dijk","doi":"10.1016/j.anndiagpath.2024.152411","DOIUrl":"10.1016/j.anndiagpath.2024.152411","url":null,"abstract":"<div><div>Fundamental and translational research in ovarian cancer aims to enhance understanding of disease mechanisms and improve treatment and survival outcomes. To support this, we established the Dutch multicenter, interdisciplinary Archipelago of Ovarian Cancer Research (AOCR) infrastructure, which includes a nationwide biobank. In this study, we share our experiences in establishing the infrastructure, offer guidance for similar initiatives, and evaluate the AOCR patient cohort. Key challenges included obtaining Data Protection Impact Assessment (DPIA) clearance, drafting the consortium agreement, and securing ethical approval from all hospitals. Over three years, 1093 patients were enrolled across 17 hospitals, resulting in the collection of 1339 tissue samples and 2280 blood samples. Of the 523 patients with currently available clinical and pathological data, 74 % (<em>n</em> = 387) had primary ovarian cancer. Among these patients, 73.4 % was diagnosed with high-grade serous ovarian carcinoma, and 80.9 % presented with advanced-stage disease. Surgery was performed on 93 % of patients with primary ovarian cancer, and chemotherapy was administered to 90.4 % of these patients. In conclusion, the AOCR biobank has established a robust foundation for future fundamental and translational ovarian cancer research. This manuscript provides valuable insights and guidance for developing future research infrastructures and biobanks, and contains detailed information about the AOCR patient cohort to date.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"74 ","pages":"Article 152411"},"PeriodicalIF":1.5,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142704969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence score-predicted value derived from estrogen receptor, tumor-infiltrating lymphocytes, progesterone receptor, and Ki-67 may substitute for the Oncotype DX recurrence score in estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)− breast cancer 根据雌激素受体、肿瘤浸润淋巴细胞、孕酮受体和 Ki-67 得出的复发评分预测值可替代雌激素受体(ER)+/人表皮生长因子受体 2(HER2)-乳腺癌的 Oncotype DX 复发评分。
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-11-16 DOI: 10.1016/j.anndiagpath.2024.152410
Keiichi Sotome , Hinako Maeda , Takako Yanagisawa , Yuko Harada , Yuuki Mae , Masashi Ogiso , Hiroyuki Sako , Nobushige Yabe , Hisashi Yanaihara , Noriki Kamiya , Yoshiyuki Ishii , Akiyoshi Hoshino , Ichiro Maeda , Akihiko Suto , Masahiko Watanabe , Tadashi Ikeda
Oncotype DX is the only multigene assay supported by the National Comprehensive Cancer Network (USA) with Level 1 evidence for use on node-negative and postmenopausal node-positive patients with estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)-breast cancer to predict the prognosis and to estimate chemotherapy add-on effects. However, the test's high cost prevents its use in most cases. Therefore, we aimed to obtain an alternative recurrence score (RS) prediction formula using the optimal clinicopathological factors. We retrospectively reviewed data of 81 patients with ER+/HER2− primary breast cancer in our hospital where Oncotype DX RS was measured. Stepwise multivariate linear regression analysis was conducted with several selected clinicopathological factors of 60 consecutive cases in the training group. The obtained RS-predicted values were validated against Oncotype DX RS using 21 additional consecutive cases. The RS prediction formula derived from the combination of ER, tumor-infiltrating lymphocytes (TILs), progesterone receptor (PgR), and Ki-67-labeling index produced a favorable model with a correlation coefficient (r) of 0.731103 for the Oncotype DX RS (p = 0.0002) and an adjusted R2 coefficient of 0.510013. The RS-predicted values and the actual Oncotype DX RS were classified into four 2 × 2 groups, by using an RS of 26 as a threshold for adding chemotherapy with a concordance rate of 95.2 % (20/21) and a kappa coefficient of 0.829. RS-predicted values of combined ER, TILs, PgR, and Ki-67 may be an appropriate substitute for Oncotype DX RS in certain situations.
Oncotype DX 是美国国家综合癌症网络(National Comprehensive Cancer Network,USA)支持的唯一一种多基因检测方法,具有 1 级证据,可用于雌激素受体(ER)+/人表皮生长因子受体 2(HER2)-乳腺癌的结节阴性和绝经后结节阳性患者,以预测预后和估计化疗的附加效果。然而,该测试的高昂费用阻碍了它在大多数情况下的应用。因此,我们的目标是利用最佳临床病理因素获得另一种复发评分(RS)预测公式。我们回顾性分析了本院81名ER+/HER2-原发性乳腺癌患者的数据,并对Oncotype DX RS进行了测量。我们对训练组中 60 例连续病例的若干临床病理因素进行了逐步多元线性回归分析。利用另外 21 个连续病例,将获得的 RS 预测值与 Oncotype DX RS 进行了验证。由ER、肿瘤浸润淋巴细胞(TIL)、孕酮受体(PgR)和Ki-67标记指数组合得出的RS预测公式产生了一个良好的模型,与Oncotype DX RS的相关系数(r)为0.731103(p = 0.0002),调整后的R2系数为0.510013。将 RS 预测值和实际 Oncotype DX RS 分成 4 个 2 × 2 组,以 RS 为 26 作为加入化疗的阈值,吻合率为 95.2 %(20/21),卡帕系数为 0.829。在某些情况下,RS 预测的ER、TIL、PgR 和 Ki-67 的综合值可适当替代 Oncotype DX RS。
{"title":"Recurrence score-predicted value derived from estrogen receptor, tumor-infiltrating lymphocytes, progesterone receptor, and Ki-67 may substitute for the Oncotype DX recurrence score in estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)− breast cancer","authors":"Keiichi Sotome ,&nbsp;Hinako Maeda ,&nbsp;Takako Yanagisawa ,&nbsp;Yuko Harada ,&nbsp;Yuuki Mae ,&nbsp;Masashi Ogiso ,&nbsp;Hiroyuki Sako ,&nbsp;Nobushige Yabe ,&nbsp;Hisashi Yanaihara ,&nbsp;Noriki Kamiya ,&nbsp;Yoshiyuki Ishii ,&nbsp;Akiyoshi Hoshino ,&nbsp;Ichiro Maeda ,&nbsp;Akihiko Suto ,&nbsp;Masahiko Watanabe ,&nbsp;Tadashi Ikeda","doi":"10.1016/j.anndiagpath.2024.152410","DOIUrl":"10.1016/j.anndiagpath.2024.152410","url":null,"abstract":"<div><div>Oncotype DX is the only multigene assay supported by the <span>National Comprehensive Cancer Network</span> (USA) with Level 1 evidence for use on node-negative and postmenopausal node-positive patients with estrogen receptor (ER)+/human epidermal growth factor receptor 2 (<span><span>HER2</span></span>)-breast cancer to predict the prognosis and to estimate chemotherapy add-on effects. However, the test's high cost prevents its use in most cases. Therefore, we aimed to obtain an alternative recurrence score (RS) prediction formula using the optimal clinicopathological factors. We retrospectively reviewed data of 81 patients with ER+/HER2− primary breast cancer in our hospital where Oncotype DX RS was measured. Stepwise multivariate linear regression analysis was conducted with several selected clinicopathological factors of 60 consecutive cases in the training group. The obtained RS-predicted values were validated against Oncotype DX RS using 21 additional consecutive cases. The RS prediction formula derived from the combination of ER, tumor-infiltrating lymphocytes (TILs), progesterone receptor (PgR), and Ki-67-labeling index produced a favorable model with a correlation coefficient (r) of 0.731103 for the Oncotype DX RS (<em>p</em> = 0.0002) and an adjusted R<sup>2</sup> coefficient of 0.510013. The RS-predicted values and the actual Oncotype DX RS were classified into four 2 × 2 groups, by using an RS of 26 as a threshold for adding chemotherapy with a concordance rate of 95.2 % (20/21) and a kappa coefficient of 0.829. RS-predicted values of combined ER, TILs, PgR, and Ki-67 may be an appropriate substitute for Oncotype DX RS in certain situations.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"74 ","pages":"Article 152410"},"PeriodicalIF":1.5,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Diagnostic Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1